Approval · Notice of Compliance 9627 · 2008
PRO-INDAPAMIDE: Notice of Compliance 9627
Issued June 16, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9627
- Date
- June 16, 2008
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Diuretic / antihypertensive agent
- Canadian reference product
- LOZIDE (Servier Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRO-INDAPAMIDE | 02312530 | Cancelled Post Market |
| PRO-INDAPAMIDE | 02312549 | Cancelled Post Market |
Medicinal ingredients
- INDAPAMIDE 1.25 MG per TAB
- INDAPAMIDE 2.5 MG per TAB